A collaborative approach to amyloidosis and a multidisciplinary care framework - position statement from the International Society of Amyloidosis [0.03%]
国际淀粉样变性学会关于淀粉样变性的协作方法和多学科护理框架立场声明
Vaishali Sanchorawala,Ashutosh Wechalekar,Peter Mollee et al.
Vaishali Sanchorawala et al.
Tafamidis treatment and neuropsychiatric dysfunction in patients with cardiac aTTR: a post-hoc analysis of the ATTRACT trial [0.03%]
甲状腺素转运蛋白心脏淀粉样变患者tafamidis治疗与神经精神功能障碍：ATTRACT试验的事后分析研究
Lark Steafo,Ujala Zubair,Julie George et al.
Lark Steafo et al.
Change of guard at Amyloid - a tribute to outgoing Editor in Chief, Professor Per Westermark [0.03%]
淀粉样蛋白新老主编交接——向Per Westermark教授致以崇高敬意
Shaji Kumar
Shaji Kumar
Failure to screen for monoclonal proteins in patients who undergo bone scintigraphy for suspected cardiac amyloidosis [0.03%]
怀疑心脏淀粉样变性接受骨扫描的患者中未筛查单克隆蛋白
Adam Devine,Anja Selland,Jose Arriola-Montenegro et al.
Adam Devine et al.
A comparison of single versus combination mechanism treatment for transthyretin amyloid cardiomyopathy [0.03%]
转甲状腺素蛋白淀粉样变性心肌病的单药与联合疗法比较研究
Vrinda Gupta,Lisa R Yanek,Bairavi Shankar et al.
Vrinda Gupta et al.
Amyloid myopathy in the internal oblique muscle of patients with wild-type transthyretin cardiac amyloidosis [0.03%]
野生型转甲状腺素蛋白心肌淀粉样变患者内斜肌淀粉样肌病的临床表现及病理特征
Koji Takahashi,Takaaki Iwamura,Yoshiyasu Hiratsuka et al.
Koji Takahashi et al.
Looking beyond left ventricular wall thickness: the search for cardiac amyloidosis in women [0.03%]
不要局限于左心室壁厚度的测量：寻找女性的心脏淀粉样变性
Carolina Lemos,Ersilia M DeFilippis
Carolina Lemos
A cautionary case series: tafamidis mistreatment following erroneous diagnosis of transthyretin cardiac amyloidosis [0.03%]
误诊后塔法米디斯治疗不当的病例系列告诫
Eli Muchtar,Hilda Gonzalez Bonilla,Vaishali Sanchorawala et al.
Eli Muchtar et al.
Medin and transthyretin: a new amyloid double act in the aortic wall and valves [0.03%]
Medin和转运蛋白 transthyretin：主动脉壁和瓣膜中新的淀粉样双重组合
Alana Maerivoet,Rebecca Price,Riaz Akhtar et al.
Alana Maerivoet et al.
Background: Cross-seeding and co-assembly of multiple amyloid species are increasingly recognised in various organs and amyloidoses. Medin and wild-type transthyretin (TTR) both form age-related amyloid deposits and have ...